Tag: ophthalmology
AAO Announces 2025 New Fellows and Diplomates at Academy 2025 Boston
The American Academy of Optometry (AAO) recently hosted Academy 2025 Boston, in Boston, Massachusetts. During the organization’s annual meeting, the Academy welcomed a record...
BioTissue® Establishes Medical Advisory Board
BioTissue Holdings Inc. announced the formation of its Medical Advisory Board. Comprised of world-renowned ophthalmologists and optometrists, the board will provide clinical expertise and...
How Student Loan Reforms Could Impact Optometry Education
Students entering optometry school in academic year 2026-2027 will face a new limitation, as part of the One Big Beautiful Bill Act. As part...
Dr. Julie Rodman and Dr. Carl Danzig: MDs Want to See...
This editorially independent content is sponsored by Astellas.
In this episode, Julie Rodman, OD, MS, FAAO, of Nova Southeastern University College of Optometry, highlights the...
LENZ Therapeutics Announces U.S. FDA Approval of VIZZ™ for Presbyopia
LENZ Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) approved VIZZ (aceclidine ophthalmic solution) 1.44%, the first and only FDA-approved aceclidine-based eye...
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY®...
Bausch + Lomb announced that Ophthalmology and Therapy has published results from a phase 3 study which assessed the efficacy and safety of LUMIFY Preservative Free...
Podcast: Don’t Compromise Eye Health for Beauty
Listen to more WO Voices podcasts here.
Would you like to be a guest on WO Voices? Contact us.
Breaking the Mold: Carving Out Your Own Path as an OD
In the heart of Las Vegas, Tami Le, OD, has transformed her knowledge in optometry into a passion project—a thriving dry eye spa. At...
ViGeneron Rebrands as VeonGen Therapeutics, Earns FDA Rare Pediatric Disease Status
VeonGen Therapeutics, formerly known as ViGeneron, announced its rebranding to reflect its evolution into a clinical-stage genetic medicine company focused on developing transformative gene...
Alcon Announces FDA Approval of TRYPTRY Drops for Dry Eye
Alcon has announced the U.S. Food and Drug Administration (FDA) has approved TRYPTYR® (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment...
